Scaling up pediatric HIV care and treatment in Africa: Clinical site characteristics associated with favorable service utilization

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 1, 2013, Pages

  Adjorlolo Johnson, Georgette ^a   Wahl Uheling, Andrea ^a   Ramachandran, Shobana ^a   Strasser, Susan ^a   Kouakou, Joseph ^a   Tindyebwa, Denis ^a   Alons, Cathrien ^a   Neluheni, Tshiwela ^a   Lee, Stephen ^a   Marlink, Richard ^b  

^a ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Africa; AIDS; care and treatment; health systems; HIV; pediatric

Indexed keywords

ANTIRETROVIRUS AGENT;

AFRICA; ARTICLE; CHILD; EARLY DIAGNOSIS; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOME CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUTRITION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS TRANSMISSION;

ADOLESCENT; AFRICA; CHILD; CHILD, PRESCHOOL; HEALTH SERVICES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MEDICATION ADHERENCE; RETROSPECTIVE STUDIES;

EID: 84872074539     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182706401     Document Type: Article

References (34)

1. WHO/UNAIDS/UNICEF. Toward Universal Access: Scaling Up Priority HIV/AIDS-Interventions in the Health Sector. Progress report. 2010. Available at: http://www.who.int/hiv/pub.
2. Newell ML, Brahmbhatt H, Ghys PD. Child mortality and HIV infection in Africa: a review. AIDS. 2004;18(suppl 2):S27-S34.
3. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
4. Matida LH, Marcopito LF, Succi RC, et al. Improving survival among Brazilian children with perinatally-acquired AIDS. Braz J Infect Dis. 2004;8:419-423.
5. Song R, Jelagat J, Dzombo D, et al. Efficacy of highly active antiretroviral therapy in HIV-1-infected children in Kenya. Pediatrics. 2007;120: e856-e861.
6. Wamalwa DC, Farquhar C, Obimbo EM, et al. Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic Syndr. 2007;45:311-317.
7. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359: 2233-2244.
8. Patel K, Hernan MA, Williams PL, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis. 2008;46:507-515.
9. Chiappini E, Galli L, Tovo PA, et al. Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy. BMC Infect Dis. 2009;9:140.
10. Dollfus C, Le Chenadec J, Faye A, et al. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10). Clin Infect Dis. 2010; 51:214-224.
11. Edmonds A, Yotebieng M, Lusiama J, et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med. 2011;8:e1001044.
12. McConnell MS, Byers RH, Frederick T, et al. Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr. 2005;38:488-494.
13. Committee on Pediatric AIDS, Section on International Child Health. Increasing antiretroviral drug access for children with HIV infection. Pediatrics. 2007;119:838-845.
14. Cherutich P, Inwani I, Nduati R, et al. Optimizing paediatric HIV care in Kenya: challenges in early infant diagnosis. Bull World Health Organ. 2008;86:155-160.
15. Castelli F, Pietra V, Diallo I, et al. Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we need in real life? Open AIDS J. 2010;4:28-32.
16. Waning B, Diedrichsen E, Jambert E, et al. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. BMC Pediatr. 2010;10:74.
17. Williams PL, Van Dyke R, Eagle M, et al. Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study. Am J Epidemiol. 2008;167:1375-1386.
18. Braitstein P, Katshcke A, Shen C, et al. Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya. Trop Med Int Health. 2010;15:833-841.
19. Anaky MF, Duvignac J, Wemin L, et al. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ. 2010;88:490-499.
20. Hassan AS, Sakwa EM, Nabwera HM, et al. Dynamics and constraints of early infant diagnosis of HIV infection in Rural Kenya. AIDS Behav. 2012; 16:5-12.
21. Barth RE, Tempelman HA, Moraba R, et al. Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality. AIDS Res Treat. 2011;2011:ID434375.
22. Sutcliffe CG, Bolton-Moore C, van Dijk JH, et al. Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study. BMC Pediatr. 2010;10:54.
23. Davies MA, Keiser O, Technau K, et al. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730-737.
24. Barker PM, McCannon CJ, Mehta N, et al. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization. J Infect Dis. 2007;196(suppl 3):S457-S463.
25. Chatterjee A, Tripathi S, Gass R. Implementing services for Early Infant Diagnosis (EID) of HIV: a comparative descriptive analysis of national programs in four countries. BMC Public Health. 2011;11:553.
26. Sherman GG, Stevens G, Jones SA, et al. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr. 2005;38:615-617.
27. Fischer A, Lejczak C, Lambert C, et al. Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J Clin Microbiol. 2004;42:16-20.
28. Marston M, Zaba B, Salomon JA, et al. Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr. 2005;38:219-227.
29. Sunguya BF, Poudel KC, Otsuka K, et al. Undernutrition among HIV-positive children in Dar es Salaam, Tanzania: antiretroviral therapy alone is not enough. BMC Public Health. 2011;11:869.
30. Madec Y, Germanaud D, Moya-Alvarez V, et al. HIV prevalence and impact on renutrition in children hospitalised for severe malnutrition in Niger: an argument for more systematic screening. PLoS One. 2011;6:e22787.
31. Anema A, Zhang W, Wu Y, et al. Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries. Public Health Nutr. 20138-47.
32. Mate KS, Bennett B, Mphatswe W, et al. Challenges for routine health system data management in a large public programme to prevent motherto-child HIV transmission in South Africa. PLoS One. 2009;4:e5483.
33. Kiragga AN, Castelnuovo B, Schaefer P, et al. Quality of data collection in a large HIV observational clinic database in sub-Saharan Africa: implications for clinical research and audit of care. J Int AIDS Soc. 2011;14:3.
34. Garrib A, Stoops N, McKenzie A, et al. An evaluation of the District Health Information System in rural South Africa. S Afr Med J. 2008;98:549-552.